The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
European Academy of Andrology guideline Management of oligo‐astheno‐teratozoospermia
Open accessAbstract
Summary: Background: Oligo‐astheno‐teratozoospermia is frequently reported in men from infertile couples. Its etiology remains, in the majority of cases, unknown with a variety of factors to contribute to its pathogenesis. The aim of this European Academy of Andrology guideline was to provide an overview of these factors and to discuss available management options. Materials and Methods: PubMed was searched for papers in English for articles with search terms: male infertility and oligo‐astheno‐teratozoospermia. For evidence‐based recommendations, the GRADE system was applied. Issues related to urogenital infections/inflammations have not been included in this document as they will be covered by separate guidelines. Results: For men with oligo‐astheno‐teratozoospermia, the European Academy of Andrology recommends: A general physical examination to assess signs of hypogonadism. A scrotal physical examination to assess (i) the testes and epididymes for volume and consistency, (ii) deferent ducts for total or partial absence, and (iii) occurrence of varicocoele. Performing two semen analyses, according to World Health Organization guidelines to define an oligo‐astheno‐teratozoospermia. An endocrine evaluation. A scrotal ultrasound as part of routine investigation. Karyotype analysis and assessment of Yq microdeletions in infertile men with a sperm concentration ≤5 × 10 6/mL. Cystic fibrosis transmembrane conductance regulator gene evaluation in case of suspicion for incomplete congenital obstruction of the genital tract. Against quitting physical activity to improve the chance of achieving pregnancy. Against androgen replacement therapy to improve the chance of achieving pregnancy. Assisted reproduction techniques to improve the chance of achieving pregnancy, in case other treatment options are not available or not efficient. Androgen replacement therapy in patients with biochemical/clinical signs of hypogonadism, after completion of the fertility treatment. Conclusion: These guidelines can be applied in clinical work and indicate future research needs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2354 · Cited by 1,954
Oxidative stress and male infertility—a clinical perspective
Tremellen, K. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmn004 · Cited by 1,507
Sperm Morphology, Motility, and Concentration in Fertile and Infertile Men
Guzick, D. S., Overstreet, J. W., Factor-Litvak, P., Brazil, C. K., Nakajima, S. T., Coutifaris, C., Carson, S. A., Cisneros, P., Steinkampf, M. P., Hill, J. A., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003005 · Cited by 1,336
European Association of Urology Guidelines on Male Infertility: The 2012 Update
Jungwirth, A., Giwercman, A., Tournaye, H., Diemer, T., Kopa, Z., Dohle, G., & Krausz, C. (2012) · European Urology · doi:10.1016/j.eururo.2012.04.048 · Cited by 1,033
Self-citationSperm chromatin damage impairs human fertility
Spanò, M., Bonde, J. P., Hjøllund, H. I., Kolstad, H. A., Cordelli, E., & Leter, G. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00462-8 · Cited by 719
Sperm DNA integrity assessment in prediction of assisted reproduction technology outcome
Bungum, M., Humaidan, P., Axmon, A., Spano, M., Bungum, L., Erenpreiss, J., & Giwercman, A. (2007) · Human Reproduction · doi:10.1093/humrep/del326 · Cited by 703
Self-citationBMI in relation to sperm count: an updated systematic review and collaborative meta-analysis
Sermondade, N., Faure, C., Fezeu, L., Shayeb, A. G., Bonde, J. P., Jensen, T. K., Van Wely, M., Cao, J., Martini, A. C., Eskandar, M., et al. (2013) · Human Reproduction Update · doi:10.1093/humupd/dms050 · Cited by 662
Gonadotrophin-releasing hormone antagonists for assisted reproductive technology
Al-Inany, H. G., Youssef, M. A., Ayeleke, R. O., Brown, J., Lam, W. S., & Broekmans, F. J. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001750.pub4 · Cited by 600
World Health Organization (1992) · Fertility and Sterility · doi:10.1016/s0015-0282(16)55089-4 · Cited by 526
Baazeem, A., Belzile, E., Ciampi, A., Dohle, G., Jarvi, K., Salonia, A., Weidner, W., & Zini, A. (2011) · European Urology · doi:10.1016/j.eururo.2011.06.018 · Cited by 486
Cited by
Agarwal, A., Parekh, N., Panner Selvam, M. K., Henkel, R., Shah, R., Homa, S. T., Ramasamy, R., Ko, E., Tremellen, K., Esteves, S., et al. (2019) · The World Journal of Men's Health · doi:10.5534/wjmh.190055 · Cited by 474
Self-citationCorona, G., Goulis, D. G., Huhtaniemi, I., Zitzmann, M., Toppari, J., Forti, G., Vanderschueren, D., & Wu, F. C. (2020) · Andrology · doi:10.1111/andr.12770 · Cited by 431
Self-citationNordenström, A., Ahmed, S. F., van den Akker, E., Blair, J., Bonomi, M., Brachet, C., Broersen, L. H. A., Claahsen-van der Grinten, H. L., Dessens, A. B., Gawlik, A., et al. (2022) · European Journal of Endocrinology · doi:10.1530/eje-22-0073 · Cited by 108
Self-citationCannarella, R., Shah, R., Hamoda, T. A.-A. A.-M., Boitrelle, F., Saleh, R., Gul, M., Rambhatla, A., Kavoussi, P., Toprak, T., Harraz, A. M., et al. (2024) · The World Journal of Men's Health · doi:10.5534/wjmh.230034 · Cited by 47
Self-citationWen, Y., Wang, X., Zheng, R., Dai, S., Li, J., Yang, Y., & Shen, Y. (2023) · Journal of Medical Genetics · doi:10.1136/jmg-2022-108727 · Cited by 10
Metadata
- Authors
- Colpi, G. M., Francavilla, S., Haidl, G., Link, K., Behre, H. M., Goulis, D. G., Krausz, C., & Giwercman, A.
- Venue
- Andrology
- Publisher
- Wiley
- Published
- 2018-07
- Volume
- 6
- Issue
- 4
- Pages
- 513-524
- ISSN
- 2047-2919 (ISSN-L)
- 2047-2927
- OpenAlex
- W2885277203
- Cited by
- 267
- References
- 64
- FWCI
- 17.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: European Academy of Andrology guideline Management of oligo‐astheno‐teratozoospermia. https://app.cochat.ai/papers/10.1111/andr.12502
- The paper
- Colpi, G. M., Francavilla, S., Haidl, G., Link, K., Behre, H. M., Goulis, D. G., Krausz, C., & Giwercman, A. (2018). European Academy of Andrology guideline Management of oligo‐astheno‐teratozoospermia. Andrology. https://doi.org/10.1111/andr.12502
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
